Güllü Görgün

Güllü Görgün is an accomplished executive in the field of oncology and hematology, currently serving as Executive Director and Senior Global Project Leader at AstraZeneca since May 2021. Prior experience includes leadership positions at Novartis as Director of Immunooncology from January 2018 to May 2021, where Güllü was instrumental in developing biomarker and diagnostics strategies for advanced clinical trials. Academic contributions as Assistant Professor of Medicine at Oregon Health and Science University and The Knight Cancer Institute focused on translational research in immuno-oncology, particularly in multiple myeloma. Earlier roles at Dana-Farber Cancer Institute included both Instructor in Medicine and Post-Doctoral Fellow, contributing to research on tumor immune microenvironments and interactions in hematologic malignancies. Güllü holds a Ph.D. in Medical Biology and Genetic from Gazi University and a Master’s degree in Tumor Biology and Immunology from Hacettepe University.